Fabian Garcia was named Chief Executive Officer of Clorox Co /De/, effective January 5, 2027. As of November 6, 2026, Clorox Co /De/ has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from May 28, 2026 to October 29, 2026, naming 4 appointments and 1 departure (Form 8-K, October 29, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Clorox Co /De/? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: In · Person: Fabian Garcia · Role: Chief Executive Officer · Effective: 2027-01-05 · 8-K, 2026-10-29
- · In / out: In · Person: Chris Hyder · Role: Chief Operating Officer · Effective: 2026-06-17 · 8-K, 2026-06-17
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-05-28
Clorox Co /De/ reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-05-28 to 2026-10-29. They name 5 people, with 4 appointments and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Clorox Co /De/ files it.
Also on the record for Clorox Co /De/
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 27, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 6.3% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 7.35% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| July 17, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 8.1% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Clorox Co /De/ now and the warning signs.
Free to see. No signup.
Keep reading
More on Clorox Co /De/ and the records around it.
Clorox Co /De/ elsewhere on the record
Companies that share a holder
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Clorox Co /De/
Get an email when Clorox Co /De/ files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Clorox Co /De/?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Clorox Co /De/: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Clorox Co /De/ covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-29 | In | Chief Executive Officer | 2027-01-05 | 8-K, 2026-10-29 | |
| 2026-10-29 | Out | Director | 8-K, 2026-10-29 | ||
| 2026-10-29 | In | Chair of the Board | 8-K, 2026-10-29 | ||
| 2026-06-17 | In | Chief Operating Officer | 2026-06-17 | 8-K, 2026-06-17 | |
| 2026-06-17 | In | Executive Vice President | 2026-06-17 | 8-K, 2026-06-17 | |
| 2026-05-28 | Reported | not named in the filing | 8-K, 2026-05-28 |
Who leads Clorox Co /De/, as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Executive Officer: Fabian Garcia, appointed, effective 2027-01-05 (filed 2026-10-29).
- Chair of the Board: Matthew J. Shattock, appointed (filed 2026-10-29).
- Director: Linda Rendle, departure reported (filed 2026-10-29). No successor is named in these filings.
- Executive Vice President: Nina Barton, appointed, effective 2026-06-17 (filed 2026-06-17).
- Chief Operating Officer: Chris Hyder, appointed, effective 2026-06-17 (filed 2026-06-17).
New leaders reset buying decisions — get the Full Report on Clorox Co /De/: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Executive Officer at Clorox Co /De/, with the record behind each one.
Find candidates like Chief Executive Officer at Clorox Co /De/Every change, in the filing's words
Appointed: Fabian Garcia, Chief Executive Officer, effective 2027-01-05
On October 28, 2026, the Board of Directors (the "Board") of The Clorox Company (the "Company"), appointed Fabian Garcia to serve as the Chief Executive Officer ("CEO") of the Company and a member of the Board, effective as of January 5, 2027 (the "Effective Date").
Departing: Linda Rendle, Director
Linda Rendle will step down from her role as CEO of the Company and Chair and a member of the Board as of the Effective Date and will serve as a senior advisor to the Company through April 2, 2027, to assist with transition matters.
Appointed: Matthew J. Shattock, Chair of the Board
As of the Effective Date, Matthew J. Shattock, currently Lead Independent Director of the Board, will serve as Independent Chair of the Board.
- In connection with this role, Mr. Shattock will receive an Independent Chair retainer of $225,000 in addition to the annual director retainer and annual grant of deferred stock units, each paid in line with our non-employee director compensation practices.
- Mr. Garcia, age 66, has served as Business Group President, Personal Care at Unilever PLC ("Unilever") since 2022.
- He joined Unilever as the President of Unilever North America in 2020 and before that, was the CEO of Revlon, Inc. from 2016 to 2018.
- Mr. Garcia previously held various positions at the Colgate-Palmolive Company from 2003 to 2016, including Chief Operating Officer, Global Innovation and Growth.
- Earlier in his career, he held a series of global leadership roles at Procter & Gamble.
- Mr. Garcia currently serves on the Board of Directors of Wells Fargo, having previously served on the Boards of Directors of Kimberly-Clark and Arrow Electronics.
- Mr. Garcia will not receive additional compensation for his service as a director of the Company.
- Offer Letter with Mr. Garcia In connection with Mr. Garcia's appointment as CEO, the Company entered into an offer letter, dated October 27, 2026, with Mr. Garcia (the "Offer Letter").
Appointed: Chris Hyder, Chief Operating Officer, effective 2026-06-17
On June 14, 2026, the Management Development and Compensation Committee (the "MDCC") of the Board of Directors of The Clorox Company (the "Company") appointed Chris Hyder, age 51, to be Executive Vice President and Chief Operating Officer ("COO") effective June 17, 2026.
Appointed: Nina Barton, Executive Vice President, effective 2026-06-17
Also on June 14, 2026, Nina Barton, formerly Executive Vice President and Group President - Care & Connection, was appointed Executive Vice President and Chief Growth & Strategy Officer, effective June 17, 2026.
- In connection with Mr. Hyder's appointment, on June 14, 2026, the MDCC approved an increase in Mr. Hyder's base salary to $800,000 and an increase in his short-term incentive target from 90% to 100% of his salary, effective as of June 17, 2026.
- In addition, on June 17, 2026, Mr. Hyder will receive a grant of restricted stock units that have an aggregate fair value of $4,000,000, which will vest in three years.
Reported
(b) On May 26, 2026, Linda Rendle, Chair of the Board of Directors (the "Board") and Chief Executive Officer ("CEO") of The Clorox Company (the "Company"), asked the Board to initiate a CEO search process, as she has made the decision to step down for health reasons.
- Ms. Rendle will remain as Chair and CEO while the search is conducted and until the new CEO is appointed.
- Ms. Rendle will also serve in an advisory role for a period following the appointment to drive business performance and a smooth leadership transition.
Tools for this story
Each opens in a new tab, filled in for Clorox Co /De/. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.